We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


SLAS to Sponsor Educational Sessionsat Two Renowned Europen Scientific Conferences

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "SLAS to Sponsor Educational Sessionsat Two Renowned Europen Scientific Conferences "

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

“Developing these partnerships gives us a unique opportunity to work toward fulfilling our mission of providing education and encouraging the study and practice of laboratory science and technology,” says Michelle Palmer, SLAS President.

Palmer continued, “By offering guest sessions at both conferences, our leadership will connect and make an impact with scientists around the globe, as well as continue supporting our young scientists in the field of drug discovery.”

SLAS is sponsoring the Assay Development and Screening session at Drug Discovery 2011, hosted by the European Laboratory Robotics Interest Group (ELRIG), September 7-8, Manchester Central Convention Complex, Manchester, England, United Kingdom.

Impacted by recent developments in assay chemistry and biology, detection technology, automation and informatics, scientists must modify their current high throughput screening (HTS) practices.

In this session, chaired by Jeff Paslay, Ph.D., SLAS Director and Richard Eglen, Ph.D.,Corning Inc., the following industry leaders will emphasize the issues of integrating innovative techniques with existing HTS approaches:

• Stuart Baddeley, GlaxoSmithKline
• Gary Clark, BioFocus
• Ulrich Hassiepen, Novartis
• Stephen Rees, AstraZeneca
• Frank Stuhmeier, Pfizer
• Paul van Midwoud, ETH Zurich

SLAS is also sponsoring the Drug Discovery Technology session at MipTec, September 20-22, Congress Center, Basel, Switzerland.

Improving the drug discovery process has been a recent hot topic among the laboratory automation and technology community, with global organizations working to develop new therapies and technologies.

The session, co-chaired by SLAS member Al Kolb, Ph.D., will educate attendees about the early-stage and future products and techniques under development at research institutes and young technology companies, and will feature enlightening presentations by the following experts:

• Janos Vörös, Swiss Federal Institute of Technology
• Roland Zengerle, University of Freiburg
• Christoph Riethmüller, Center for Nanotechnology
• Karl Stefansson, deCODE Genetics
• Robert Brown, University College London
• Stefan Przyborski, Durham University
• Jens Kelm, InSphero
• Phillip Lee, CellASIC
• Akwasi Minta, TEF Labs
• Sabrina Desbordes, Center for Genomic Regulation
• Johannes Ottl, Novartis Pharma

At both ELRIG Drug Discovery 2011 and MipTec, students, graduates and post-docs will compete for the SLAS Young Scientist Award.

The winner of this poster competition at each event will be invited to present and participate in the Student Poster Competition at the First Annual SLAS Conference and Exhibition, February 4-8, 2012 at the San Diego Convention Center, San Diego, CA, USA.

SLAS Young Scientist Award winners receive a $500 cash prize, roundtrip coach airfare, shared hotel accommodations and conference registration for SLAS2012.